Tinavi Medical Technologies Co.,Ltd. (SHA:688277)
China · Delayed Price · Currency is CNY 18.42
+0.01 (0.05%)
Aug 15, 2025, 3:00 PM CST
SHA:688277 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | -124.27 | -121.13 | -156.39 | -110.58 | -79.93 | -54.47 | Upgrade |
Depreciation & Amortization | 37.2 | 37.2 | 40.61 | 44.51 | 35.31 | 8.25 | Upgrade |
Other Amortization | 5.79 | 5.79 | 4.11 | 5.65 | 6.3 | 8.62 | Upgrade |
Loss (Gain) From Sale of Assets | -5.64 | -5.64 | -0 | 0.01 | - | - | Upgrade |
Asset Writedown & Restructuring Costs | 0.26 | 0.26 | 0.03 | 0.74 | 0.42 | 1.92 | Upgrade |
Loss (Gain) From Sale of Investments | -40.4 | -40.4 | -56.22 | -0.1 | -3.57 | -7.71 | Upgrade |
Provision & Write-off of Bad Debts | 4.58 | 4.58 | 1.38 | -2.53 | 5.77 | 0.94 | Upgrade |
Other Operating Activities | 49.9 | 11.14 | 6.03 | 2.19 | 0.63 | 0.31 | Upgrade |
Change in Accounts Receivable | -5.25 | -5.25 | -86.69 | -2.44 | -25.02 | 26.85 | Upgrade |
Change in Inventory | -5.56 | -5.56 | 14.07 | -6.1 | -3.31 | -7.05 | Upgrade |
Change in Accounts Payable | -33.06 | -33.06 | 26.92 | 11.97 | 20.18 | -19.02 | Upgrade |
Change in Other Net Operating Assets | 31.84 | 31.84 | 25.13 | 1 | -12.55 | -1.98 | Upgrade |
Operating Cash Flow | -63.04 | -98.65 | -170.5 | -87.51 | -77.76 | -57.58 | Upgrade |
Capital Expenditures | -29.05 | -36.69 | -221.03 | -59.59 | -238.66 | -132.17 | Upgrade |
Sale of Property, Plant & Equipment | 0.21 | 0.11 | 0.01 | - | - | - | Upgrade |
Divestitures | 26 | 52 | 11.81 | - | - | - | Upgrade |
Investment in Securities | 56.17 | 59.61 | -49.51 | 66.48 | 127.73 | 25.65 | Upgrade |
Other Investing Activities | 0.59 | 0.71 | 0.55 | 2.73 | 12.2 | 6.76 | Upgrade |
Investing Cash Flow | 53.92 | 75.74 | -258.17 | 9.62 | -98.73 | -99.76 | Upgrade |
Long-Term Debt Issued | - | 62.01 | 201.17 | 25 | - | - | Upgrade |
Total Debt Issued | 71.62 | 62.01 | 201.17 | 25 | - | - | Upgrade |
Long-Term Debt Repaid | - | -83.9 | -27.94 | -22.94 | -28.91 | - | Upgrade |
Total Debt Repaid | -90.92 | -83.9 | -27.94 | -22.94 | -28.91 | - | Upgrade |
Net Debt Issued (Repaid) | -19.3 | -21.89 | 173.23 | 2.06 | -28.91 | - | Upgrade |
Issuance of Common Stock | 62.08 | 29.8 | 363.7 | - | 7.02 | 468.12 | Upgrade |
Common Dividends Paid | -8.37 | -9.06 | -4.68 | -0.76 | - | - | Upgrade |
Other Financing Activities | -0.39 | -0.64 | -3.94 | - | 17.08 | 4.99 | Upgrade |
Financing Cash Flow | 34.01 | -1.79 | 528.3 | 1.3 | -4.8 | 473.11 | Upgrade |
Foreign Exchange Rate Adjustments | 0.54 | 0.64 | -0.17 | 0.65 | - | - | Upgrade |
Net Cash Flow | 25.43 | -24.06 | 99.47 | -75.93 | -181.29 | 315.77 | Upgrade |
Free Cash Flow | -92.09 | -135.34 | -391.53 | -147.1 | -316.42 | -189.75 | Upgrade |
Free Cash Flow Margin | -44.17% | -75.68% | -186.41% | -94.18% | -202.80% | -139.61% | Upgrade |
Free Cash Flow Per Share | -0.21 | -0.30 | -0.88 | -0.35 | -0.75 | -0.49 | Upgrade |
Cash Income Tax Paid | - | 5.54 | -4.3 | -4.85 | 2.71 | 7.03 | Upgrade |
Levered Free Cash Flow | -69.69 | -116.7 | -307.34 | -111.36 | -315.47 | -165.36 | Upgrade |
Unlevered Free Cash Flow | -64.02 | -110.98 | -303.32 | -108.89 | -313.38 | -165.36 | Upgrade |
Change in Working Capital | 9.54 | 9.54 | -10.06 | -27.39 | -42.7 | -15.43 | Upgrade |
Updated Oct 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.